Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.00
Bid: 53.50
Ask: 56.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.607%)
Open: 55.00
High: 55.00
Low: 55.00
Prev. Close: 55.00
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

27 May 2022 07:00

RNS Number : 0043N
Baronsmead Second Venture Trust PLC
27 May 2022
 

Baronsmead Second Venture Trust plc

Half-yearly report for the six months ended 31 March 2022

 

The Directors of Baronsmead Second Venture Trust plc are pleased to announce the unaudited half-yearly financial report for the six months to 31 March 2022. Copies of the half-yearly report can be obtained from the following website: www.baronsmeadvcts.co.uk

Our investment objective

· Baronsmead Second Venture Trust plc (the "Company") is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax free dividends.

Investment policy

· To invest primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

· Investments are made selectively across a range of sectors in companies that have the potential to grow and enhance their value.

Dividend policy

· The Board will, where possible, seek to pay two dividends to shareholders in each calendar year, typically an interim dividend in September and a final dividend following the Annual General Meeting in February.

· The Board will use, as a guide, when setting the dividends for a financial year, a sum representing 7 per cent. of the opening NAV of that financial year.

 

Key elements of the business model

Access to an attractive, diverse portfolio Baronsmead Second Venture Trust plc gives shareholders access to a diverse portfolio of growth businesses.

 

The Company will make investments in growth businesses, whether unquoted or traded on AIM, which are substantially based in the UK in accordance with the prevailing VCT legislation. Investments are made selectively across a range of sectors.

 

The Manager's approach to investing The Manager endeavours to select the best opportunities and applies a distinctive selection criteria based on:

 

· Primarily investing in parts of the economy which are experiencing long-term structural growth.

· Businesses that demonstrate, or have the potential for, market leadership in their niche.

· Management teams that can develop and deliver profitable and sustainable growth.

· Companies with the potential to become an attractive asset appealing to a range of buyers at the appropriate time to sell.

 

In order to ensure a strong pipeline of opportunities, the Manager invests in building deep sector knowledge and networks and undertakes significant proactive marketing to interesting target companies in preferred sectors. This approach generates a network of potentially suitable businesses with which the Manager maintains a relationship ahead of possible investment opportunities.

 

The Manager as an influential shareholder The Manager is an engaged and supportive shareholder (on behalf of the Company) in both unquoted and significant quoted investments. For unquoted investments, representatives of the Manager often join the investee board. The role of the Manager with investees is to ensure that strategy is clear, the business plan can be implemented and that the management resources are in place to deliver profitable growth. The intention is to build on the business model and grow the company into an attractive target able to be either sold or potentially floated in the medium term.

 

Strategic report

Financial highlights

-11.9% Net Asset Value (NAV) per share decreased 11.9% per cent. to 74.2p in the six months to 31 March 2022, before deduction of dividends, in the sixth months to 31 March 2022.

 

359.3p NAV total return to shareholders for every 100.0p invested at launch (January 2001).

 

£13.7mn Realised proceeds in the period, returning 2.1x cost.

 

£37.5m Funds raised in the period (before costs).

 

 

Cash returned to shareholders

 

The table below shows the cash returned to shareholders that invested in Baronsmead Second Venture Trust plc dependent on their subscription cost, including the income tax available to be reclaimed on the subscription.

Year subscribed

Cash invested

(p)

Income tax reclaim

(p)

 

Net cash invested

(p)

Cumulative dividends

paid#

 (p)

Return on cash invested# (%)

2001 (January)

100.0

20.0

80.0

157.3

177.3

2005 (March) - C share*

100.0

40.0

60.0

113.2

153.2

2010 (March)

103.1

30.9

72.2

109.0

135.7

2012 (December)

117.4

35.2

82.2

91.0

107.5

2014 (March)

112.4

33.7

78.7

71.0

93.2

2016 (February)

107.2

32.2

75.0

54.5

80.8

2017 (October)

97.5

29.2

68.2

34.5

65.4

2019 (February)

85.3

25.6

59.7

27.0

61.7

2019 (November)

78.9

23.7

55.2

19.5

54.7

2020 (January)

84.8

25.4

59.4

19.5

53.0

2020 (February)

82.5

24.8

57.7

16.0

49.4

2020 (March)

64.3

19.3

45.0

16.0

54.9

2020 (November)

77.9

23.4

54.5

13.0

46.7

2020 (December)

80.9

24.3

56.6

13.0

46.1

2021 (January)

84.4

25.3

59.1

13.0

45.4

2021 (February)

82.2

24.7

57.5

9.5

41.6

2021 (March)

84.9

25.5

59.4

9.5

41.2

2021 (December)

88.1

26.4

61.7

6.5

37.4

2022 (January)

87.1

26.1

61.0

6.5

37.5

2022 (March)

76.6

23.0

53.6

3.0

33.9

 

The total return could be higher for those shareholders who were able to defer a capital gain on subscription and the net sum invested may be less.

* Dividends paid to C shareholders post conversion have been adjusted by the conversion ratio (0.85642528).

# Includes interim dividend of 3.0p per share payable 9 September 2022.

 

Chairman's statement

The six months to 31 March 2022 saw an increased level of volatility in public markets due to greater levels of uncertainty heading into 2022. Investor fears were exacerbated by a rise in geopolitical risk in Europe as Russia invaded Ukraine, slowing economic growth and increasing expectations of a prolonged period of higher inflation driven by higher commodity prices.

 

These headwinds have been reflected mainly in the softer performance of the AIM traded investments within the portfolio in the six months to 31 March 2022. Despite the drop in the value of the portfolio over the period, the Manager believes that - in aggregate - the fundamentals of the underlying portfolio companies remain robust and the growth prospects for the majority of investee companies continue to be positive.

 

The Board is also pleased to declare an interim dividend of 3.0p to be paid on 9 September 2022 to shareholders on the register as of 12 August 2022. The dividend will be paid from realised capital profits generated from the successful sales of portfolio companies. Over the period, capital proceeds of £13.7mn were realised from the sale, or partial sale, of four portfolio companies. The combined return from these sales was 2.1x invested cost.

 

I must, of course, remind shareholders that payment dates and the amount of future dividends depend on the level and timing of profitable realisations and cannot be guaranteed.

 

Results

 

During the six months to 31 March 2022, the Company's NAV per share decreased 11.9 per cent. from 84.3p to 74.2p after the payment of a final dividend of 3.5p per share on 4 March 2022. The table below breaks down the movement in NAV over the six months.

 

 

 

Pence per ordinary share

NAV as at 1 October 2021 (after deducting the final dividend of 3.5p)

84.3

Valuation decrease (11.9 per cent.)

(10.1)

NAV as at 31 March 2022

74.2

The 30 April 2022 NAV was 75.1p, a 1.2 per cent. increase driven by slightly firmer quoted markets.

 

Portfolio review

The table below provides a summary of each asset class and the return generated during the period under review.

 

Asset class

NAV*

(£m)

% of NAV*

Number of investees**

% return in the period***

Unquoted

54

22

35

(5)

AIM and LSE-traded companies

84

35

49

(18)

LF Gresham House UK Micro Cap Fund

29

12

48

(16)

LF Gresham House UK Multi Cap Income Fund

13

6

46

(1)

LF Gresham House UK Smaller Companies Fund

6

2

44

(10)

Liquid assets#

57

23

-

-

Total

243

100

222

-

 

*By value at 31 March 2022.**Includes investee companies with holdings by more than one fund. Total number of individual companies held is 173.***Return includes interest received on unquoted realisations during the period.

#Represents cash, OEICs and net current assets.

 

The value of the unquoted portfolio decreased 5 per cent. in the six months to 31 March 2022. The drop in value of the unquoted portfolio was driven by a combination of softer trading performance in several e-commerce assets and a general de-rating of valuation multiples in the consumer and marketing services sectors. These declines were partially offset by uplifts in healthcare investments which continue to grow strongly and to benefit from the long-term structural growth drivers in this market.

 

The value of the Company's portfolio of investments directly held in AIM-traded companies decreased 18 per cent. in the six months to 31 March 2022. The value of the Company's investment into the LF Gresham House UK Micro Cap Fund decreased by 16 per cent., the LF Gresham House UK Smaller Companies Fund decreased by 10 per cent. and the LF Gresham House Multi Cap Income Fund decreased by 1 per cent. This was primarily driven by negative investor sentiment surrounding inflationary pressures, expectations of interest rate rises and the cost-of-living squeeze in the UK. The implications of the ongoing war in Ukraine continue to impact negatively on global equity markets, with a particularly pronounced effect on UK and European equities.

 

Investments and divestments

 

The Company's investments and divestments during the period are set out below.

 

Investments

 

I am pleased to report that the Company made five new investments totalling £8.5mn and two follow-on investments with a combined value of £1.8mn in the six months to 31 March 2022. Below are descriptions of the new investments made:

 

· Aptamer (quoted) - platform providing antibody alternatives to the pharma industry across a range of applications.

 

· Oberon (quoted) - corporate advisory business providing advice, asset management and deal arrangement services.

 

· Popsa (unquoted) - provider of a mobile app that lets users design photo albums digitally and have them delivered in print.

 

· Proximity Insight (unquoted) - platform used by front-line sales associates of omni-channel retailers to better engage and transact with their customers.

 

· Skillcast (quoted) - provider of staff compliance training.

 

 

During the period the Company also invested £4.1mn into the LF Gresham House UK Multi Cap Income Fund and £1.4mn into the LF Gresham House Smaller Companies Fund.

 

Following the period end, four further follow-on investments were made, totalling £4.3mn and a new unquoted investment of £0.9mn was made into Bidnamic, a market leading provider of Google shopping management software.

 

Realisations

 

Proceeds of £4.4m were received during the period from sales of quoted investments, including:

 

· Cerillion plc - top-slicing delivered proceeds of £1.5mn, equating to a money multiple of 11.4x.

· Cloudcall Group plc - takeover by Xplorer Capital Management resulting in proceeds of £2.9mn and a money multiple of 0.9x.

 

 

From the unquoted portfolio, the sale of the investment in Carousel successfully completed in February 2022. The sale returned proceeds of £9.3mn, which, in addition to the loan-note interest received during the lifetime of the investment, resulted in a total gross money multiple of 5.0x original investment cost.

 

Venture capital industry

 

I would also like to draw attention to the UK Parliamentary inquiry into the venture capital industry, launched in April 2022. The Committee will be examining the regulation around venture capital, the role of key bodies and how the industry can be strengthened. The Board and Manager welcome the opportunity to provide the inquiry with the information they are seeking on how VCTs provide small UK businesses with funding to assist with their growth and development.

 

Fundraising

 

I am pleased to report that, during the period, the Company successfully raised £37.5mn (before costs) through an offer for subscription which became fully subscribed in February 2022. The Board are pleased to welcome the 1,811 new shareholders who invested for the first time and to thank the 524 existing shareholders who continue to support the Company.

 

The Board will consider whether to raise new funds in the 2022/23 tax year. This will be determined by the Company's cashflow and its anticipated requirements to fund new and follow-on investments over the next two to three years. The Board appreciates that shareholders would like plenty of notice of its fundraising intentions and will ensure that shareholders are informed of any such fundraising at the earliest practical time.

 

Investment Manager

 

The Board is pleased to see the integration progress made by the Investment Manager following the acquisition of the VCT business of Mobeus Equity Partners LLP in September 2021. The Board believes the combined platform enhances the Manager's ability to source, invest in and manage attractive early-stage unquoted investments. The Board believes that this will benefit the Company through more consistent and increased rates of investment which will ultimately support the delivery of attractive long-term performance and dividends for the Company's shareholders. We note that the Baronsmead VCTs retain their distinctive approach as hybrid VCTs; investing across the spectrum of fast growing, small, quoted and unquoted companies.

 

Following the successful integration, Fund Manager Bevan Duncan has decided to pursue a new career path as Chief Operating Officer at an early stage, high growth technology company. The Board would like to wish him every success in his next role and are reassured by the depth and experience of the wider team to continue to deliver for investors. Trevor Hope will be Managing Director for the private equity team, working closely with Ken Wotton, Managing Director of Public Equity, who continues to be responsible for the quoted portfolio within the Baronsmead VCTs. Clive Austin remains Managing Director of VCT portfolio with responsibility for portfolio and asset management alongside Ed Wass, a highly experienced portfolio partner.

 

Outlook

 

The macro-economic environment has undoubtedly become more challenging over the past six months. The Board and Manager are planning for further market volatility, ongoing pressure on companies' operating margins due to rising costs and weaker consumer demand, together with supply chain disruption and shortages of talent within portfolio companies. The Manager is regularly engaging with portfolio company management teams to forecast cash levels and expected usage rates, to plan for stress scenarios and, more generally, to reduce execution risk over the next 12 months.

 

We note that the portfolio remains highly diversified, with over 80 direct holdings, and is largely positioned in parts of the economy which the Board expects will see long-term structural growth. The volatility and disruption also provide good opportunities to invest in earlier stage, higher growth companies that are quickly moving to exploit changes in their target markets. The Company remains suitably capitalised and the Manager is well resourced to support investment into new and existing portfolio companies, which are expected to create value and provide attractive dividend payments to shareholders over the long-term.

 

Sarah Fromson

Chairman

 

26 May 2022

 

Investments in the period

 

Company

Location

Sector

Activity

Book cost

£'000

Unquoted investments

New

Popsa Holdings Ltd

Surrey

Technology

Mobile-first photobook app provider

3,379

Proximity Insight Holdings Ltd

London

Technology

Platform for front-line sales associate of omni-channel retailers to engage with customers

1,152

Follow on

Airfinity Ltd

London

Healthcare & education

Provides real time life science intelligence as a subscription service

1,039

RevLifter Ltd

London

Technology

AI platform using advanced behavioural analytics to deliver tailored promotions to users

779

Total unquoted investments

6,349

 

AIM-traded investments

New

Aptamer Group plc

Yorkshire

Healthcare & education

Platform providing antibody alternatives to the pharma industry

2,390

Skillscast Group Plc

London

Healthcare & Education

Compliance e-learning and regulatory technology services

817

Oberon Investments Group plc

London

Business services

Corporate advisory business

742

Total AIM-traded investments

3,949

Total investments in the period

10,298

 

 

 

Realisations in the period

 

Company

 

First

investment

date

Original book cost £'000

Proceeds

£'000

Overall

multiple

return

Unquoted realisations

Carousel Logistics Ltd

Full trade sale

Oct 13

2,336

9,333

5.0*

Total unquoted realisations

 

 

2,336

9,333

5.0*

AIM-traded realisations

CloudCall Group plc

Take over

Apr 14

3,214

2,900

0.9

Cerillion plc

Market sale

Jul 15

129

1,474

11.4

Mi-Pay Group plc

Liquidated

Nov 12

800

11

0.0

Total AIM-traded realisations

4,143

4,385

1.1

Total realisations in the period

6,479

13,718#

2.1

Residual book cost at realisation date.

Proceeds at time of realisation including interest.

*Includes interest/dividends received, loan note redemptions and partial realisations accounted for in prior periods.

#Deferred consideration of £15,000 was also received in respect of Glide which had been sold in a prior period.

 

Responsibility statement of the Directors in respect of the half-yearly financial report

 

Half-yearly report

 

The important events that have occurred during the period under review, the key factors influencing the financial statements and the principal uncertainties for the remaining six months of the financial year are set out in the Chairman's statement and the Strategic report.

 

The principal risks facing the Company are substantially unchanged since the date of the Company's Annual Report for the financial year ended 30 September 2021 and continue to be as set out in that Report on pages 18 and 19.

 

Risks faced by the Company include but are not limited to; loss of approval as a Venture Capital Trust, investment performance risk, legislative risk, regulatory and compliance risk, operational risk, and economic and political risk. The Board considers the COVID-19 pandemic and the Russian invasion of Ukraine to be factors which permeate these risks, and their impacts for the remaining six months of the year continue to be kept under review.

 

Responsibility statement

 

Each director confirms that to the best of our knowledge:

· the condensed set of nancial statements has been prepared in accordance with FRS 104 Interim Financial Reporting Standards and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company.

 

· This half-yearly report includes a fair review of the information required by:

a) DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the rst six months of the nancial year and their impact on the condensed set of nancial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

b) DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the rst six months of the current nancial year and that have materially affected the nancial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

The half-yearly report was approved by the Board of Directors on 26 May 2022 and was signed on its behalf by Ms Sarah Fromson, Chairman.

 

Sarah Fromson

Chairman

26 May 2022

 

 

 

Condensed income statement

For the six months to 31 March 2022 (Unaudited)

 

 

Notes

Six months to 31 March 2022

Six months to 31 March 2021

Year to 30 September 2021

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

(Losses)/gains on investments

5

-

(27,719)

(27,719)

-

37,141

37,141

-

59,071

59,071

Income

961

-

961

566

-

566

3,821

-

3,821

Investment management fee

(706)

(2,116)

(2,822)

(661)

(1,983)

(2,644)

(1,424)

(4,272)

(5,696)

Other expenses

(359)

-

(359)

(377)

-

(377)

(665)

-

(665)

(Loss)/profit before taxation

(104)

(29,835)

(29,939)

(472)

35,158

34,686

1,732

54,799

56,531

Taxation on ordinary activities

-

-

-

-

-

-

(108)

108

-

(Loss)/profit for the period, being the total comprehensive income for the period after taxation

(104)

(29,835)

(29,939)

(472)

35,158

34,686

1,624

54,907

56,531

Return per ordinary share:

 

 

 

Basic and Diluted

2

(0.04p)

(10.04p)

(10.07p)

(0.18p)

13.23p

13.05p

0.59p

19.96p

20.55p

 

All items in the above statement derive from continuing operations.

 

There are no recognised gains and losses other than those disclosed in the Income Statement.

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the realised and unrealised profit or loss on investments and the proportion of the management fee charged to capital.

 

The total column of this statement is the unaudited Statement of Total Comprehensive Income of the Company prepared in accordance with the Financial Reporting Standard ("FRS"). The supplementary revenue return and capital return columns are prepared in accordance with the Statement of Recommended Practice issued by the Association of Investment Companies ("AIC SORP").

 

Condensed statement of changes in equity

 

For the six months to 31 March 2022 (Unaudited)

 

Non-distributable reserves

Distributable reserves

 

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

Total

£'000

At 1 October 2021

 

31,206

74,231

77,481

63,698

1,758

248,374

(Loss)/profit after taxation

-

-

(34,540)

4,705

(104)

(29,939)

Net proceeds of share issues, share buybacks & sale of shares from treasury

3

4,583

31,868

-

(1,050)

-

35,401

Dividends paid

4

-

-

-

(10,465)

(308)

(10,773)

At 31 March 2022

 

35,789

106,099

42,941

56,888

1,346

243,063

 

For the six months to 31 March 2021 (Unaudited)

 

Non-distributable reserves

Distributable reserves

 

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

Total

£'000

At 1 October 2020

 

27,146

46,775

30,890

75,290

2,216

182,317

Profit/(loss) after taxation

-

-

31,462

3,696

(472)

34,686

Net proceeds of share issues, share buybacks & sale of shares from treasury

3

4,060

27,459

-

(1,608)

-

29,911

Dividends paid

4

-

-

-

(8,354)

(1,232)

(9,586)

At 31 March 2021

 

31,206

74,234

62,352

69,024

512

237,328

 

For the year ended 30 September 2021 (Audited)

 

Non-distributable reserves

Distributable reserves

Notes

Called-up share capital

£'000

Share

premium£'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

Total

£'000

At 1 October 2020

 

27,146

46,775

30,890

75,290

2,216

182,317

Profit after taxation

-

-

46,591

8,316

1,624

56,531

Net proceeds of share issues, share buybacks & sale of shares from treasury

4,060

27,456

-

(3,908)

-

27,608

Dividends paid

-

-

-

(16,000)

(2,082)

(18,082)

At 30 September 2021

31,206

74,231

77,481

63,698

1,758

248,374

 

Condensed balance sheet

As at 31 March 2022 (Unaudited)

 

Notes

 

As at

31 March

2022

£'000

As at

31 March

2021

£'000

As at 30 September 2021

£'000

Fixed assets

 

 

Unquoted investments

5

53,887

52,113

59,971

Traded on AIM

5

83,916

94,364

102,394

Collective investment vehicles

5

60,053

54,503

75,701

Listed on LSE

5

34

36

34

Investments

5

197,890

201,016

238,100

Current assets

 

 

Debtors

 

106

110

109

Cash at bank

 

46,647

37,767

12,312

 

46,753

37,877

12,421

Creditors (amounts falling due within one year)

 

(1,580)

(1,565)

(2,147)

Net current assets

 

45,173

36,312

10,274

Net assets

 

243,063

237,328

248,374

Capital and reserves

 

 

Called-up share capital

 

35,789

31,206

31,206

Share premium

 

106,099

74,234

74,231

Capital reserve

 

56,888

69,024

63,698

Revaluation reserve

5

42,941

62,352

77,481

Revenue reserve

 

1,346

512

1,758

Equity shareholders' funds

 

243,063

237,328

248,374

 

 

 

Net asset value per share

 

74.2p

83.07p

87.77p

Number of ordinary shares in circulation

 

327,596,768

285,692,452

282,974,085

 

Condensed statement of cash flows

For the six months to 31 March 2022 (Unaudited)

 

 

 

Sixmonths to 31 March 2022

£'000

Sixmonths to 31 March 2021

£'000

Year to 30 September 2021

£'000

Net cash outflow from operating activities

(2,536)

(1,670)

(1,850)

Net cash inflow from investing activities

12,689

16,050

1,083

Net cash before financing activities

10,153

14,380

(767)

Net cash inflow from financing activities

24,182

20,279

9,971

Increase in cash

34,335

34,659

9,204

Reconciliation of net cash flow to movement in net cash

 

Increase in cash

34,335

34,659

9,204

Opening cash at bank and on deposit

12,312

3,108

3,108

Closing cash at bank and on deposit

46,647

37,767

12,312

Reconciliation of (loss)/ profit/ before taxation to net cash outflow from operating activities

 

(Loss)/profit before taxation

(29,939)

34,686

56,531

Gains/(losses) on investments

27,719

(37,141)

(59,071)

Changes in working capital and other non-cash items

(316)

785

690

Net cash outflow from operating activities

(2,536)

(1,670)

(1,850)

 

 

Notes to the financial statements

 

For the six months to 31 March 2022 (Unaudited)

 

1. Basis of preparation

 

The condensed financial statements for the six months to 31 March 2022 comprise the unaudited financial statements together with the related notes. The Company applies FRS 102 and the AIC's Statement of Recommended Practice ('the SORP') for its annual Financial Statements. The condensed financial statements for the six months to 31 March 2022 have therefore been prepared in accordance with FRS 104 'Interim Financial Reporting' and the principles of the SORP. They have been prepared on a going concern basis. The financial statements have been prepared on the same basis as the accounting policies set out in the Company's Annual Report and Financial Statements for the year ended 30 September 2021.

 

The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in sections 434 - 436 of the Companies Act 2006. The half-yearly financial report for the six months ended 31 March 2022 and for the six months ended 31 March 2021 have been neither audited nor reviewed by the Company's auditors. The information for the year to 30 September 2021 has been extracted from the latest published audited financial statements, which have been filed with the Registrar of Companies. The report of the auditor for the audited financial statements for the year to 30 September 2021 was: (i) unqualified; (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report; and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006. No statutory accounts in respect of any period after 30 September 2020 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

 

Copies of the half-yearly financial report have been made available to shareholders and are available from Gresham House, 80 Cheapside, London, EC2V 6EE.

 

2. Performance and shareholder returns

 

Return per share is based on a weighted average of 297,083,965 ordinary shares in issue (31 March 2021 - 265,723,554 ordinary shares; 30 September 2021 - 275,054,819 ordinary shares).

 

Earnings for the first six months to 31 March 2022 should not be taken as a guide to the results of the full financial year to 30 September 2022.

 

3. Called-up share capital

 

The below table details the movement in called-up share capital during the period.

 

Allotted, called-up and fully paid:

 

 

 

Ordinary shares

£'000

252, 3312,059,812 ordinary shares of 10p each listed at 30 September 2021

31,206

45,829,661 ordinary shares of 10p each issued during the period

4,583

357,889,473 ordinary shares of 10p each listed at 31 March 2022

35,789

229,085,727 ordinary shares of 10p each held in treasury at 30 September 2021

(2,909)

2,090,978 ordinary shares of 10p each repurchased during the period and held in treasury

(209)

884,000 ordinary shares of 10p each sold from treasury during the period

88

30,292,705 ordinary shares of 10p each held in treasury at 31 March 2022

(3,030)

327,596,768 ordinary shares of 10p each in circulation* at 31 March 2022

32,759

*carrying one vote each

During the six months to 31 March 2022, the Company issued 45,829,661 shares at net proceeds of £36,451,000 (after costs). During the same period, the Company purchased 2,090,978 shares to be held in treasury at a cost of £1,689,000 (including costs). The Company also sold 884,000 shares from treasury for proceeds of £639,000. At 31 March 2022, the Company held 30,292,705 ordinary shares in treasury. Shares may be sold out of treasury below Net Asset Value as long as the discount at issue is narrower than the average discount at which the shares were bought into treasury.

 

Excluding treasury shares, there were 327,596,768 ordinary shares in issue at 31 March 2022 (31 March 2021 - 285,692,452 ordinary shares; 30 September 2021 - 282,974,085 ordinary shares).

 

4. Dividends

 

The final dividend for the year ended 30 September 2021 of 3.5p per share (3.4p capital, 0.1p revenue) was paid on 4 March 2022 to shareholders on the register on 4 February 2022. The ex-dividend date was 3 February 2022.

 

During the year to 30 September 2021, the Company paid an interim dividend on 10 September 2021 of 3.0p per share (2.7p capital, 0.3p revenue).

 

 

5. Investments

 

All investments are initially recognised subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.

 

The methods of fair value measurement are classified into a hierarchy based on reliability of the information used to determine the valuation.

 

· Level 1 - Fair value is measured based on quoted prices in an active market.

· Level 2 - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices.

· Level 3 - Fair value is measured using a valuation technique that is not based on data from an observable market.

 

The valuation of unquoted investments contained within level 3 of the Fair Value hierarchy involves key assumptions dependent upon the valuation methodology used. The primary methodologies applied are:

 

- Cost of recent investment

- Earnings Multiple

- Offer less 10 per cent.

 

The earnings multiple approach involves more subjective inputs than the cost of recent investment and offer approaches and therefore presents a greater risk of over or under estimation. Key assumptions for the earnings multiple approach are the selection of comparable companies and the use of either historic or forecast revenue or earnings, as considered most appropriate. Other assumptions include the appropriateness of the discount magnitude applied for reduced liquidity and other qualitative factors. These assumptions are described in more detail in Note 2.3 in the Company's Report and Financial Statements for the year to 30 September 2021. The techniques used in the valuation of unquoted investments have not changed materially since the date of that report.

 

 

Level 1

Level 2

Level 3

Traded

on AIM

£'000

 

Listed

on LSE

£'000

Collective

investment

vehicles

£'000

 

 

Unquoted

£'000

Total

£'000

Opening book cost

63,064

 

3,429

48,404

45,722

160,619

Opening unrealised appreciation/(depreciation)

39,330

(3,395)

27,297

14,249

77,481

Opening fair value

102,394

34

75,701

59,971

238,100

Movements in the period:

Purchases at cost

3,949

-

5,699

6,349

15,997

Sale - proceeds

(4,374)

-

(15,000)

(9,114)

(28,488)

- realised gains/(losses) on sales

1,037

-

-

(1,585)

(548)

Unrealised (losses) / gains realised during the period

111

-

-

7,528

7,369

Decrease in unrealised depreciation

(19,201)

-

(6,347)

(8,992)

(34,540)

Closing fair value

83,916

34

60,053

53,887

197,890

Closing book cost

63,787

3,429

39,103

48,630

154,949

Closing unrealised appreciation/(depreciation)

20,129

(3,395)

20,950

5,257

42,941

Closing fair value

83,916

34

60,053

53,887

197,890

Equity shares

83,916

34

-

25,225

109,175

Preference Shares

-

-

-

18,160

18,160

Loan notes

-

-

-

10,502

10,502

Collective investment vehicles

-

-

60,053

-

60,053

Closing fair value

83,916

34

60,053

53,887

197,890

 

 

6. Other required disclosures

6.1 Segmental reporting

 

The Company has one reportable segment being investing in primarily a portfolio of UK growth businesses, whether unquoted or traded on AIM.

 

6.2 Principal risks and uncertainties

 

The Company's assets consist of equity and fixed interest investments, shares in collective investment schemes, cash and liquid resources. Its principal risks are therefore market risk, price risk, credit risk and liquidity risk. Other risks faced by the Company include loss of approval as a Venture Capital Trust, legislative, investment performance, economic, political and other external factors, regulatory and compliance and operational risks. These risks, and the way in which they are managed, are described in more detail in the principal risks & uncertainties table within the Strategic report section in the Company's Annual Report and Accounts for the year to 30 September 2021. The Board continues to regularly review the risk environment in which the Company operates.

 

6.3 Related parties

 

Gresham House Asset Management Ltd ('the Manager') manages the investments of the Company. The Manager also provides or procures the provision of secretarial, accounting, administrative and custodian services to the Company. Under the management agreement, the Manager receives a fee of 2.5 per cent. per annum of the net assets of the Company. This is described in more detail under the heading 'The Investment Management Agreement' within the Strategic Report in the Company's Annual Report and Accounts for the year ended 30 September 2021. During the period the Company has incurred management fees of £2,822,000 (31 March 2021 - £2,644,000; 30 September 2021 - £5,696,000) and secretarial and accounting fees of £76,000 (31 March 2021 - £71,000; 30 September 2021 - £143,000) payable to the Manager. No performance fee has been accrued at 31 March 2022 (31 March 2021 - £nil; 30 September 2021 - £nil). This is described in more detail under the heading 'Performance fees' within the Strategic Report in the Company's Annual Report and Financial Statements for the year to 30 September 2021.

 

A related party relationship exists between the Company and Happy Days Consultancy Ltd, owing to the significant influence deemed to be held over the operations of the company. As at 31 March 2022, the loan balance stood at £3,510,000, including £1,122,000 of capitalised interest, as provided for in the Agreement with the company.

 

6.4 Investment in associates

 

The Company has made the presumption that the following holdings are investments in associates, owing to the proportion of equity held and representation on the board representing significant influence over the operations of the company. The investments held are held as part of an investment portfolio, and are therefore measured at fair value through profit and loss, as detailed in note 5 rather than using the equity method, as permitted by Section 14 of FRS 102:

 

 

Name

Location

Class of Shares held

% of Equity

Profit (£m)

Net Assets (£m)

Results for year ended

Happy Days Consultancy

UK

A Ordinary & B Ordinary

 

 

35.7

 

 

(3.0)

 

 

(12.7)

31 December 20201

 

1Latest published set of financial statements available at Companies House.

 

 

6.5 Going concern

 

After making enquiries, and bearing in mind the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future. In arriving at this conclusion, the Directors have considered the Company's cash balances, the liquidity of the Company's investments and the absence of any gearing. The Directors are therefore also satisfied that the Company has adequate financial resources to continue in operation for at least the next 12 months and that, accordingly, it is appropriate to adopt the going concern basis in preparing the financial statements.

 

6.6 Post balance sheet events

 

The following events occurred between the balance sheet date and the signing of these financial statements:

 

· The 30 April 2022 NAV of 75.1p was announced on 06 May 2022. At the date of publishing this report, the Board is unaware of any matter that will have caused the NAV per share to have changed significantly since the latest NAV.

· Two follow-on investments into Tribe and Panthera, completed in April 2022 totalling £2.9mn.

· Two further follow-on investments, into Yappy and Glisser, completed in May 2022 totalling £1.4mn

· One new investment, into Bidnamic, completed in May 2022, totalling £0.9mn.

 

 

 

Corporate Information

 

Directors

Sarah Fromson (Chair)†

Malcolm Groat*

Graham McDonald

Tim Farazmand#

 

Secretary

Gresham House Asset Management Ltd

 

Registered Office

5 New Street Square

London EC41 3TW

 

Investment Manager

Gresham House Asset Management Ltd

5 New Street Square

London EC41 3TW

020 7382 0999

 

Registered Number

04115341

 

 

 

 

 

 

 

 

 

 

 

 

† Chair of the Nomination Committee.

* Senior Independent Director and Chairman of the Audit Committee.

#Chairman of the Management Engagement and Remuneration Committee.

Registrars and Transfer Office

Computershare Investor Services plc

The Pavilions

Bridgwater Road

Bristol BS99 6ZZ

Tel: 0800 923 1534

 

Brokers

Panmure Gordon & Co

One New Change

London EC4M 9AF

Tel: 020 7886 2500

 

Auditor

BDO LLP

55 Baker Street

London

W1U 7EU

 

 

Solicitors

Dickson Minto W.S.

Broadgate Tower

20 Primrose Street

London EC2A 2EW

 

VCT Status Adviser

PricewaterhouseCoopers LLP

1 Embankment Place

London WC2N 6RH

 

Website

www.baronsmeadvcts.co.uk

 

 

LEI 2138008D3WUMF6TW8C28

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DBGDUSBDDGDL
Date   Source Headline
1st May 202411:11 amRNSTotal Voting Rights
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSShare Allotment, Total Voting Rights, Offer Close
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSClose of Offer to New Applications
20th Mar 20248:02 amRNSCHANGE OF ALLOTMENT DATE & EXTENSION OF THE OFFER
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:48 pmRNSDirector/PDMR Shareholding
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSIntention to Utilise Over-allotment Facility
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:46 pmRNSResult of AGM
1st Mar 202410:34 amRNSTotal Voting Rights
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20245:12 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:03 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
4th Jan 20243:46 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:46 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:26 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:05 amRNSUpdate on Offer for Subscription
6th Nov 20234:00 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
2nd Oct 20234:02 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
25th Sep 202312:28 pmRNSDirector/PDMR Shareholding
25th Sep 202312:25 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSTransaction in Own Shares - Replacement
12th Sep 20235:28 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:54 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:25 amRNSTotal Voting Rights
20th Jun 20233:40 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.